Roflumilast: a green signal is yet to come - Wikidata - awgldk - TriplyDB

Roflumilast: a green signal is yet to come

Roflumilast: a green signal is yet to come

http://www.wikidata.org/entity/Q41375399

about

Quantitative benefit-harm assessment for setting research priorities: the example of roflumilast for patients with COPD

P2860

Q35681671-F9E95F5F-AF79-4110-B219-757DA5AD07C6

P2860

Roflumilast: a green signal is yet to come

http://www.wikidata.org/entity/Q41375399

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Roflumilast: a green signal is yet to come

@en

type

label

Roflumilast: a green signal is yet to come

@en

prefLabel

Roflumilast: a green signal is yet to come

@en

P1433

Q41375399-B625FA84-FD6E-49EB-A7A5-92615622D004

P1476

Q41375399-87CB8847-0129-481D-B1CF-BF3AECCD17DC

P2093

Q41375399-C0A8E748-EE06-494C-A76F-A4C6F16F779E

Q41375399-CCFA97CF-D59E-46BF-BBDC-978BFD38B62A

P2860

Q41375399-1C8AFC12-13B5-4D98-BF7E-54700107314C

Q41375399-1D2FA760-7AC9-4E35-93F3-F85459F436CD

Q41375399-203DBF20-5964-4B06-938A-0C23AD962019

Q41375399-459F7454-BA1F-45BC-BA7A-AAE1EFCD4ADC

Q41375399-65A258A5-09FB-4214-A36C-FFA037FFA130

Q41375399-66D33E91-FBA6-4EDC-9178-56FA69373147

Q41375399-6D8FE8A9-B7F2-414C-9620-0DA790AF96E1

Q41375399-750359EA-53A2-4B18-AC9E-19A216BEAE32

Q41375399-76702855-0D55-47CD-A664-53046A4152B2

Q41375399-9C1D8882-62A9-45D6-97DB-9937370F3CFC

P304

Q41375399-228A8836-9BF1-4D92-8331-64AA74E931DA

P31

Q41375399-166cf6c6-7c82-47e1-93d3-395c3982450a

Q41375399-5DE94767-B0AE-47E0-BC58-61CD2BC04C12

P356

Q41375399-B32E5CB1-3D48-4A36-8E5F-9EFF9A0D4D7F

P433

Q41375399-3AE07403-2242-4B20-BBEB-7174A5618BF8

P478

Q41375399-FE69CF90-42F2-4ECB-8C1F-89D12E187E59

P577

Q41375399-AA3B760A-5AED-4183-920C-F4448FD0BD45

P698

Q41375399-4BEEDCEF-2119-4B43-B8BB-BD193FA61A78

P932

Q41375399-269791E3-AC57-42B4-B23D-8469CE705F54

P356

J.ISSN.2072-1439.2013.05.11

P1433

Journal of thoracic disease

P1476

Roflumilast: a green signal is yet to come

@en

P2093

Nazir Lone

http://www.w3.org/2001/XMLSchema#string

Yuji Oba

http://www.w3.org/2001/XMLSchema#string

P2860

Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care.

Adverse effects of corticosteroids on the cardiovascular system.

Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials.

An update and appraisal of the cilomilast Phase III clinical development programme for chronic obstructive pulmonary disease.

Corticosteroids: do they damage the cardiovascular system?

Changing the burden of COPD mortality

Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT).

Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease

P304

213-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3978/J.ISSN.2072-1439.2013.05.11

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2013-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23825748

http://www.w3.org/2001/XMLSchema#string

P932

3698285

http://www.w3.org/2001/XMLSchema#string